Clinical Research

EARLY TAVR update: New data highlight continued benefits of treating asymptomatic aortic stenosis
Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026.
Shockwave Medical announces new studies evaluating carotid IVL platform
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data
All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.
Pigeons excel at spotting abnormalities on CT scans
Researchers believe pigeons' perceptual processes could be used to develop artificial intelligence applications in radiology.
Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis
TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.

PHOTO GALLERY: Highlights from ACC.24 in Atlanta

ACC.24, the American College of Cardiology's annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in person to take in the excitement.

PET/MRI may reduce unnecessary prostate biopsies by 83%

A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

Video of Gregg Stone, MD, explaining the late-breaking RELIEVE-HF trial he presented at ACC.24 this week. #ACC24 #ACC2024

Inter-atrial shunt in RELIEVE-HF improves symptoms in HFrEF, but not HFpEF

Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.

AI able to assess invasiveness of lung lesions to aid in surgery

In a study, the most accurate model combined deep-learning with a radionomics approach.

Video of Howard Herrmann, MD, explaining the details of the SMART trial that looked at TAVR in small annulus and found self-expanding TAVR valves work better in these patients than balloon-expanding TAVR.

Cardiologist highlights key takeaways from SMART trial, which looked at TAVR in small annulus patients

Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli.

Ultrasound-damaged organoids show how brain injury may progress into ALS

Seeking ways to protect the brain, the researchers found a gene called KNNJ2 that aids in muscle contraction and relaxation.

Ultrasound specialists update recommendations for endometriosis screening

The authors recommend tweaking pelvic ultrasound with new maneuvers that produce clearer images.

ACC.24, the annual meeting of the American College of Cardiology (ACC), kicked off on Saturday, April 6, with a series of late-breaking clinical trials focused on testing the safety and effectiveness of new treatment strategies.

Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments

ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies.

Clinical Research

EARLY TAVR update: New data highlight continued benefits of treating asymptomatic aortic stenosis

Shockwave Medical announces new studies evaluating carotid IVL platform

TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data

Pigeons excel at spotting abnormalities on CT scans

Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis